Clozapine

Product NDC: 0378-0973
11-digit product format: 003780973
Labeler code: 0378
Product ID: 0378-0973_a8cef9ad-4bf9-4289-9473-400c8f1a95ac
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: clozapine
Dosage form: TABLET
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: ANDA075417
Marketing category: ANDA
Marketing start: 2010-04-20
Substance: CLOZAPINE
Active strength: 200 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0378-0973	0378-0973-02	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075417-001	CLOZAPINE	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27
A075417-002	CLOZAPINE	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27
A075417-003	CLOZAPINE	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15
A075417-004	CLOZAPINE	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15
A075417-005	CLOZAPINE	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A075417-001	AB
A075417-002	AB
A075417-004	AB
A075417-005	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 210 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-001	CLOZAPINE	25MG	TABLET / ORAL	AB	1999-05-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-002	CLOZAPINE	100MG	TABLET / ORAL	AB	1999-05-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-003	CLOZAPINE	12.5MG	TABLET / ORAL		2010-04-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-004	CLOZAPINE	50MG	TABLET / ORAL	AB	2010-04-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-005	CLOZAPINE	200MG	TABLET / ORAL	AB	2010-04-15	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A075417-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075417-005	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075417-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075417-005	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075417-005	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075417-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075417-005	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075417-005	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075417-005	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-004	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075417-005	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-004	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075417-005	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075417-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075417-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075417-004	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075417-005	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075417-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075417-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075417-004	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075417-005	AB	1	`d8e5a09893c0…`

Additional Listing Data#

Finished product: Yes
Brand name base: Clozapine
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CLOZAPINE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
J60AR2IKIC	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197535	Internal RxNorm lookup
197536	Internal RxNorm lookup
309374	Internal RxNorm lookup
429212	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
883b5d43-0339-7dc1-f775-93791fb9b978	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fde12e54-43fa-cc16-3015-4c000a7b8d3e	Product name	5	20250812
0901063f-b37f-4bf1-8be6-1e2a469e57bc	Product name	2	20180209
e01fb60f-a608-2c68-dfdd-23e6433ece68	Product name	5	20180209
7a7f58c4-be43-7e82-4dfc-128bbed4230a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0378-0973-01	Clozapine	100 in 1 BOTTLE, PLASTIC	TABLET	100		35
0378-0973-02	Clozapine	100 in 1 BOTTLE, PLASTIC	TABLET	100		35

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0378-0973-01	EA - Each	0378-0973	8fa974d4-ad52-4880-9e8f-6bf1e22406ad	1	2012-07-24
0378-0973-02	EA - Each	0378-0973	6d9af17c-1659-4ac9-8e65-2ba7b91431a0	1	2021-06-02
0378-0973-05	EA - Each	0378-0973	6a831832-9c8a-4145-a601-fdda3289122c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CLOZAPINE	ACTIVE INGREDIENT	J60AR2IKIC	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
CLOZAPINE	ACTIVE MOIETY	J60AR2IKIC	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	13
CLOZAPINE	ACTIVE INGREDIENT	J60AR2IKIC	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
CLOZAPINE	ACTIVE MOIETY	J60AR2IKIC	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0378-0973	CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.]	32	Current NDC, Legacy NDC, 2 package rows	20250417_883b5d43-0339-7dc1-f775-93791fb9b978.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clozapine	CLOZAPINE	Mylan Pharmaceuticals Inc.	883b5d43-0339-7dc1-f775-93791fb9b978	2026-04-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075417 application number: ANDA075417 ndc (product): 0378-0973
Clozapine	CLOZAPINE	Safecor Health LLC	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2026-03-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075417 application number: ANDA075417
Clozapine	CLOZAPINE	Mylan Institutional Inc.	d5c8a456-6f3c-4963-b321-4ed746f690e4	2025-11-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075417 application number: ANDA075417

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
J60AR2IKIC	CLOZAPINE	5786-21-0	CLOZAPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197535	cloZAPine 100 MG Oral Tablet	PSN	883b5d43-0339-7dc1-f775-93791fb9b978	35
309374	cloZAPine 200 MG Oral Tablet	PSN	883b5d43-0339-7dc1-f775-93791fb9b978	35
197536	cloZAPine 25 MG Oral Tablet	PSN	883b5d43-0339-7dc1-f775-93791fb9b978	35
429212	cloZAPine 50 MG Oral Tablet	PSN	883b5d43-0339-7dc1-f775-93791fb9b978	35
197535	clozapine 100 MG Oral Tablet	SCD	883b5d43-0339-7dc1-f775-93791fb9b978	35
309374	clozapine 200 MG Oral Tablet	SCD	883b5d43-0339-7dc1-f775-93791fb9b978	35
197536	clozapine 25 MG Oral Tablet	SCD	883b5d43-0339-7dc1-f775-93791fb9b978	35
429212	clozapine 50 MG Oral Tablet	SCD	883b5d43-0339-7dc1-f775-93791fb9b978	35
197535	cloZAPine 100 MG Oral Tablet	PSN	d5c8a456-6f3c-4963-b321-4ed746f690e4	19
309374	cloZAPine 200 MG Oral Tablet	PSN	d5c8a456-6f3c-4963-b321-4ed746f690e4	19
197536	cloZAPine 25 MG Oral Tablet	PSN	d5c8a456-6f3c-4963-b321-4ed746f690e4	19
197535	clozapine 100 MG Oral Tablet	SCD	d5c8a456-6f3c-4963-b321-4ed746f690e4	19
309374	clozapine 200 MG Oral Tablet	SCD	d5c8a456-6f3c-4963-b321-4ed746f690e4	19
197536	clozapine 25 MG Oral Tablet	SCD	d5c8a456-6f3c-4963-b321-4ed746f690e4	19
197535	cloZAPine 100 MG Oral Tablet	PSN	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2
309374	cloZAPine 200 MG Oral Tablet	PSN	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2
197536	cloZAPine 25 MG Oral Tablet	PSN	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2
197535	clozapine 100 MG Oral Tablet	SCD	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2
309374	clozapine 200 MG Oral Tablet	SCD	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2
197536	clozapine 25 MG Oral Tablet	SCD	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0378-0973-01	00378097301	100 TABLET in 1 BOTTLE, PLASTIC (0378-0973-01)	100 tablet	2010-04-20	0000-00-00	No	No	Current
0378-0973-02	00378097302	100 TABLET in 1 BOTTLE, PLASTIC (0378-0973-02)	100 tablet	2020-10-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Clozapine	Mylan Pharmaceuticals Inc.	2026-04-15	HUMAN PRESCRIPTION DRUG LABEL	35
Clozapine	Safecor Health LLC	2026-03-09	HUMAN PRESCRIPTION DRUG LABEL	2
Clozapine	Mylan Institutional Inc.	2025-11-11	HUMAN PRESCRIPTION DRUG LABEL	19